Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 3937 - 3944 of 12099 results
Disclosure Considerations Regarding Operations, Liquidity, and Capital Resources
July 21, 2020| Advisory| Viewpoint
Further Update on FDA’s Comprehensive Regenerative Medicine Framework: November 2020 Deadline Extended by Six Months
July 21, 2020| Blog| Viewpoint
Bipartisan Group of Senators Introduces Legislation to Waive 340B Eligibility Requirements Due to COVID-19
July 21, 2020| Blog| Viewpoint
Protecting Trade Secrets in the COVID-19 Era
July 21, 2020| Video| Viewpoint
Strategies for Adjusting Executive Performance Goals in the Covid-19 Era
July 20, 2020| Advisory| Viewpoint
Don’t Get Schooled: What You Can Learn from the Wave of Trade Secret Cases That Followed the 2007-2008 Financial Crisis
July 20, 2020| Blog| Viewpoint
Update: United States and Canada Agree to Restrict Non-Essential Travel Across Shared Border for an Additional 30 Days
July 20, 2020| Blog| Viewpoint
Democrats Lay Groundwork for Infrastructure & Clean Energy Ahead of General Election
July 20, 2020| Blog| Viewpoint
News & Press Releases
Mintz Advises on Equillium, Inc.'s up to $50 Million PIPE
August 15, 2025
Mintz advised the lead placement agent in connection with an up to $50 million private placement by Equillium, Inc. The PIPE was comprised of (i) an initial upfront closing of approximately $30 million in gross proceeds in exchange for approximately 52.6 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), and (ii) the potential for up to an additional $20 million in gross proceeds in exchange for up to approximately 35.1 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), subject to achieving specified milestones related to clinical study initiation and share price.
Eleven Mintz Attorneys Named to 2025 IAM Strategy 300 List of Leading IP Strategists
August 14, 2025
Mintz announces that eleven of its attorneys have been named to the 2025 IAM Strategy 300: The World's Leading IP Strategists list, which recognizes individuals for their trailblazing work in developing and implementing strategies that maximize the value of intellectual property portfolios.
ESG-Focused Activism Persists Despite Proxy Curbs
August 12, 2025
Law360 published an article written by Mintz Members Jacob Hupart, Ellen Shapiro, and Associate Will McKitterick about the role ESG considerations continue to play in shareholder activism and proxy battles. The article also examines how recent regulatory and political developments have raised the bar for ESG-related proposals, influencing both strategy and outcomes.
Events
Podcasts
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|